Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 6Ovarian Neoplasms 5Small Cell Lung Carcinoma 4Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Breast Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Sarcopenia 1Recurrence 1Pancreatic Neoplasms 1PROMs 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Hearing Loss 1Fatigue 1Fallopian Tube Neoplasms 1Eunuchism 1Esophageal Neoplasms 1Erectile Dysfunction 1Chemotherapy-induced Peripheral Neuropathy 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 1Radiosurgery 1Genetic Association Studies 1Drug Therapy 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hearing Loss × Carboplatin × Clear all
NCT05633719 2022-12-01

Multicenter, Prospective Observational Study for Early Diagnosis, and Development of Follow-up Protocol and Hearing Rehabilitation Program for Ototoxic Hearing Loss After Chemotherapy for Pediatric Solid Cancer

Seoul National University Hospital

Not yet recruiting
300 enrolled

Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡